Surgery, Abdominal Transplant Surgery

• 

  People

  • Professorships

    • Kirk, Allan Douglas, David C. Sabiston, Jr. Distinguished Professor of Surgery
    • Knechtle, Stuart Johnston, William R. Kenan, Jr. Distinguished Professor

  • Primary Appointments

    • Barbas, Andrew Serghios, Assistant Professor of Surgery
    • Collins, Bradley Henry, Associate Professor of Surgery
    • Jackson, Annette M, Associate Professor in Surgery
    • Kirk, Allan Douglas, Professor of Surgery
    • Knechtle, Stuart Johnston, Professor of Surgery
    • Kwun, Jean, Assistant Professor in Surgery
    • McElroy, Lisa M, Assistant Professor of Surgery
    • Ravindra, Kadiyala Venkata, Professor of Surgery
    • Rege, Aparna Sharad, Clinical Associate in the Department of Surgery
    • Sudan, Debra L, Professor of Surgery
    • Vikraman Sushama, Deepak, Assistant Professor of Surgery

  • Secondary Appointments

    • Chambers, Eileen Tsai, Associate Professor in the Department of Surgery
    • Ellis, Matthew Jay, Assistant Professor in Surgery
    • Luo, Xunrong, Professor in Surgery
    • Mavis, Alisha Michelle, Assistant Professor in Surgery
• 

  Administers Grant

  • A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QPI-1002 FOR PREVENTION OF DELAYED GRAFT FUNCTION IN RECIPIENTS OF A DONATION AFTER BRAIN DEATH OLDER DONOR KIDNEY TRANSPLANT (ReGIFT)
  • A Phase 2a Randomized open label study to assess Bleselumab
  • A Phase 3 prospective, randomized, multicenter, open-label, controlled trial to assess the efficacy and safety of cellular immunotherapy with MDR-101 for induction of immune tolerance in recipients of HLA-Matched, living donor kidney transplants
  • A Prospective, Open-Label, Long-Term Safety and Efficacy of Teduglutide
  • A multi-center, randomized double-blind, three-arm, parallel-group trial to assess the efficacy and safety of NTRA-9620 in infants with short bowel syndrome (SBS) following surgical resection
  • A multicenter randomized, controlled trial to compare the efficacy of ex-vivo normothermic machine perfusion with static cold storage in human liver transplantation
  • A multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of apraglutide in adult subjects with short bowel syndrome and intestinal failure (SBS-IF)
  • A randomized, parallel-group, double-blind, placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function
  • ASTS Presidential Student Mentor Grant
  • ASTS Presidential Student Mentor Grant
  • ASTS-Alexion Presidential Student Mentor Grant
  • Acoustic based plasmapheresis to prevent antibody-mediated organ transplant
  • Alexion Sponsored Research Agreement
  • Allo Vir ALVR105
  • American Journal of Transplantation
  • BMS-EnList
  • CD57+CD4+ T cells in Belatacept-resistant Renal Allograft Rejection
  • Developing clinically relevant immunosuppressive regimen for pig to rhesus kidney transplantation using transgenic pigs
  • EP396: HLA Reporter Cell Lines for Desensitization Trials
  • EVALUATION OF PATIENT OUTCOMES FROM THE KIDNEY ALLOGRAFT OUTCOMES ALLOSURE REGISTRY (KOAR)
  • EVALUATION OF PATIENT OUTCOMES FROM THE KIDNEY ALLOGRAFT OUTCOMES ALLOSURE REGISTRY (KOAR) AGREEMENT
  • Effects of storage method on intestinal allograft immune profile and viability
  • Evaluation of Acute Rejection Rates in de novo Renal Transplant Recipients Following Thymoglobulin Induction, CNI-free, Nulojix (belatacept) -based Immunosuppression
  • Gene therapy of discarded human kidney grafts during 48 hours ex-vivo machine perfusion
  • IM101-823 - Abatacept for treatment of recurrent or de novo autoimmune hepatitis
  • IMAGINE
  • ITN089ST (ADAPT) - Measuring Allospecific Impact Of Belatacept/Carfilzomib Desensitization
  • ITN089ST Measuring Allospecific Impact of Belatacept/Carfilzomib Desensitization Protocol Chair
  • ITN336 Immune Tolerance Network
  • LET vs VGCV for Prevention of CMV disease in Kidney Transplant Recipients
  • Living Donor Kidney Transplant: Establishing the Phenotype of an Equitable Program
  • Lung Transplant Plasmapheresis (PLEX)/Belatacept/Carfilzomib Protocol for Treatment of Antibody Mediated Rejection (AMR) and Desensitization
  • Measuring the Impact of Allosensitization on Xenotransplantation
  • Novartis - CCFZ533A2202 - Liver Transplant Patients
  • Novartis - CFZ533A2201 Study for Kidney Transplant Patients
  • Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17
  • Phase2 Prospective, Multi-center, Open-label, Controlled Trial to Assess the Safety and Efficacy of Cellular Immunotherapy with MDR-103 for Induction of Mixed Chimerism and Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kid
  • Preventing allograft rejection but not tolerance by blockade of the lymphocyte store-operated calcium channel
  • Prevention of Homograft Induced Cardiac Allograft Vasculopathy in Pediatric Heart Transplantation
  • Prevention of Homograft Induced Cardiac Allograft Vasculopathy in Pediatric Heart Transplantation
  • Proposal for preliminary proof of concept studies with Plasmin in transplantation
  • Prospective, Randomized, Controlled, Multicenter, Multi-National, Pivotal, Clinical Investigation Evaluating the Safety and Efficacy of HEMOBLASTTM Bellows in Cardiothoracic, Abdominal, and Orthopedic Lower Extremity Surgeries
  • Sample Collection for Prospera Enhancement by Detecting dd-cfDNA Levels (PEDAL Study)
  • Short Bowel Syndrome Registry
  • T Cell Maturation and the Nexus of Viral- and Allo-Immunity
  • Talaris Therapeutics - FCR001A2301 FREEDOM-1 Study
  • Targeting complement C2 in a sensitized rat cardiac allograft model
  • Targeting complement C3 to prevent acute antibody-mediated rejection for a deceased-donor kidney transplant in sensitized recipients
  • Targeting complement activation steps in antibody-mediated rejection
  • Targeting mitochondrial dysfunction and damage-associated molecular patterns to improve the function of high risk grafts in liver transplantation
  • Targeting the B Cell Response to Treat Antibody-Mediated Rejection
  • The Delivery of AAV Vector to Liver Allograft using Machine Perfusion System
  • The Risks and Opporunities of Homeostatic Repopulation
  • Transplant Genomics - TruGraf testing
  • Transplant Tolerance in Non-Human Primates
  • Transplant Tolerance in Non-Human Primates
  • Transplant Tolerance in Non-Human Primates
  • TruGraf Long-term Clinical Outcomes Study - Pro00108037
  • Use of Sirtuin-1 Activators to Mitigate Ischemia-Reperfusion Injury after Liver Transplantation
  • Visiting Research Fellowship

Add data to my Website